10.05
Schlusskurs vom Vortag:
$10.19
Offen:
$10.15
24-Stunden-Volumen:
2.23M
Relative Volume:
1.34
Marktkapitalisierung:
$1.18B
Einnahmen:
$260.81M
Nettoeinkommen (Verlust:
$20.48M
KGV:
77.31
EPS:
0.13
Netto-Cashflow:
$22.67M
1W Leistung:
-3.92%
1M Leistung:
-0.50%
6M Leistung:
-11.30%
1J Leistung:
-14.76%
Dynavax Technologies Corp Stock (DVAX) Company Profile
Firmenname
Dynavax Technologies Corp
Sektor
Telefon
(510) 848-5100
Adresse
2100 POWELL STREET, EMERYVILLE, CA
Vergleichen Sie DVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DVAX
Dynavax Technologies Corp
|
10.05 | 1.19B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Herabstufung | Goldman | Neutral → Sell |
| 2024-02-01 | Eingeleitet | Goldman | Neutral |
| 2022-09-27 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-01-06 | Fortgesetzt | Goldman | Buy |
| 2021-08-06 | Eingeleitet | Goldman | Buy |
| 2020-08-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-15 | Eingeleitet | Evercore ISI | Outperform |
| 2019-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-07-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-05-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-03-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-02-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-09-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-07-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-07-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2013-11-25 | Hochstufung | MLV & Co | Hold → Buy |
| 2013-02-25 | Herabstufung | MLV & Co | Buy → Hold |
| 2012-11-16 | Bestätigt | MLV & Co | Buy |
Alle ansehen
Dynavax Technologies Corp Aktie (DVAX) Neueste Nachrichten
What institutional flow reveals about Dynavax Technologies CorporationTrade Risk Report & Safe Entry Point Identification - newser.com
Can Dynavax Technologies Corporation stock reach $100 price target2025 Technical Overview & Stepwise Trade Execution Plans - newser.com
Will Dynavax Technologies Corporation stock maintain dividend yieldJuly 2025 Movers & Daily Volume Surge Signals - newser.com
What MACD and RSI say about Dynavax Technologies CorporationJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
How Dynavax Technologies Corporation stock responds to policy changesRate Hike & Risk Managed Investment Entry Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockEarnings Risk Summary & Fast Entry High Yield Tips - newser.com
Will Dynavax Technologies Corporation (DYF1) stock benefit from Fed rate cutsWeekly Trade Recap & Entry Point Confirmation Alerts - newser.com
Will Dynavax Technologies Corporation (DYF1) stock deliver compounding returns2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Why Dynavax Technologies Corporation stock is popular among millennialsWeekly Profit Report & Accurate Buy Signal Notifications - newser.com
Using data tools to time your Dynavax Technologies Corporation exitJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com
Will Dynavax Technologies Corporation price bounce be sustainableJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - newser.com
139,227 Shares in Dynavax Technologies Corporation $DVAX Purchased by Y Intercept Hong Kong Ltd - MarketBeat
How Dynavax Technologies Corporation stock performs after earningsTrade Entry Summary & Community Verified Watchlist Alerts - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favorite2025 Volatility Report & Smart Allocation Stock Tips - newser.com
What sentiment indicators say about Dynavax Technologies Corporation stockSell Signal & High Yield Stock Recommendations - newser.com
Strategies to average down on Dynavax Technologies Corporation2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Will Dynavax Technologies Corporation (DYF1) stock deliver stable dividends2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationMarket Trend Review & Fast Exit Strategy with Risk Control - newser.com
Using data models to predict Dynavax Technologies Corporation stock movement2025 Analyst Calls & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-10-31 00:23:52 - newser.com
Dynavax Technologies (DVAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
How interest rate cuts could boost Dynavax Technologies Corporation stockEarnings Beat & High Accuracy Swing Trade Signals - newser.com
Finanzdaten der Dynavax Technologies Corp-Aktie (DVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dynavax Technologies Corp-Aktie (DVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):